Covered recipient · General Payments record
JOHN M BOOZAN
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$4,066.73
- Reported across 76 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $970.33 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GLAUKOS CORPORATION | $457.10 | 5 |
| Amgen Inc. | $202.89 | 15 |
| Bausch & Lomb Americas Inc. | $124.78 | 1 |
| ABBVIE INC. | $81.19 | 1 |
| Mallinckrodt Hospital Products Inc. | $56.24 | 3 |
| CooperVision Inc. | $18.41 | 1 |
| Tarsus Pharmaceuticals, Inc. | $14.91 | 1 |
| Alcon Laboratories Inc | $14.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $81.19 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103348544 | CMS |
| Alcon Vision LLC | $14.81 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110566995 | CMS |
| Amgen Inc. | $6.34 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533304 | CMS |
| Amgen Inc. | $3.48 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533306 | CMS |
| Amgen Inc. | $4.25 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533308 | CMS |
| Amgen Inc. | $8.72 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533310 | CMS |
| Amgen Inc. | $9.92 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533312 | CMS |
| Amgen Inc. | $5.00 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533314 | CMS |
| Amgen Inc. | $120.29 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533322 | CMS |
| Amgen Inc. | $5.21 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533320 | CMS |
| Amgen Inc. | $7.84 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533316 | CMS |
| Amgen Inc. | $6.03 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533318 | CMS |
| Amgen Inc. | $2.98 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533324 | CMS |
| Amgen Inc. | $5.38 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533326 | CMS |
| Amgen Inc. | $5.07 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533328 | CMS |
| Amgen Inc. | $6.84 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533330 | CMS |
| Amgen Inc. | $5.54 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111533332 | CMS |
| Bausch & Lomb Americas Inc. | $124.78 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140371027 | CMS |
| CooperVision Inc. | $18.41 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145504043 | CMS |
| Glaukos Corporation | $134.84 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151980436 | CMS |
| Glaukos Corporation | $12.90 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151993683 | CMS |
| Glaukos Corporation | $143.42 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151975532 | CMS |
| Glaukos Corporation | $17.58 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151977770 | CMS |
| Glaukos Corporation | $148.36 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151993685 | CMS |
| Mallinckrodt Hospital Products Inc. | $21.35 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145051186 | CMS |
| Mallinckrodt Hospital Products Inc. | $20.12 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145051188 | CMS |
| Mallinckrodt Hospital Products Inc. | $14.77 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145051190 | CMS |
| Tarsus Pharmaceuticals, Inc. | $14.91 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139083870 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.